Positive scores from CRISPR-based lymphocyte–tumor co-culture screens indicated that DDR1 disruption sensitizes tumor cells to cytotoxic T and NK cells, while adverse (positive) associations with ICB survival were consistently observed in several independent cohorts. The gene discussed is DDR1; the disease is neoplasm.